Safety and immunogenicity following a homologous booster dose of a SARS-CoV-2 recombinant spike protein vaccine (NVX-CoV2373): a secondary analysis of a randomised, placebo-controlled, phase 2 trial
Resource Type
Article
Authors
Adams, Mark ; Arya, Mark ; Athan, Eugene ; Berger, Ira ; Bradley, Paul ; Briskin, Toby ; Glover II, Richard ; Griffin, Paul ; Kim, Joshua ; Kitchener, Scott ; Klein, Terry ; Leah, Amber ; Leelasena, Indika ; Lemech, Charlotte ; Lickliter, Jason ; Manning, Mary Beth ; Napier-Flood, Fiona ; Nugent, Paul ; Thackwray, Susan ; Turner, Mark ; Mallory, Raburn M ; Formica, Neil ; Pfeiffer, Susan ; Wilkinson, Bethanie ; Marcheschi, Alex ; Albert, Gary ; McFall, Heather ; Robinson, Michelle ; Plested, Joyce S ; Zhu, Mingzhu ; Cloney-Clark, Shane ; Zhou, Bin ; Chau, Gordon ; Robertson, Andreana ; Maciejewski, Sonia ; Hammond, Holly L ; Baracco, Lauren ; Logue, James ; Frieman, Matthew B ; Smith, Gale ; Patel, Nita ; Glenn, Gregory M
Source
In The Lancet Infectious Diseases November 2022 22(11):1565-1576
Subject
Primary Research Articles
Language
ISSN
1473-3099